Novartis AG (NVS) by event type
NVS moves most on analyst downgrades — a median of -0.31% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the NVS overview →
How NVS reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,272 of 2,717 | 20 | +0.03% | 55% | +0.27% |
| Analyst downgrades 2,014 of 2,603 | 15 | -0.31% | 20% | -0.43% |
| Coverage initiations 1,492 of 2,283 | 14 | -0.09% | 43% | +0.28% |
| Rating reiterations 1,583 of 3,522 | 26 | 0.00% | 39% | +0.06% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how NVS usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · NVS overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IQVIA Holdings, Inc. (IQV) | 329 | +0.02% | 51% |
| DBV Technologies S.A. - American Depositary Shares (DBVT) | 327 | -0.15% | 40% |
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.